Thomas Andersson
Corporate Officer/Principal bei KAROLINSKA DEVELOPMENT AB
Profil
Thomas B.
Andersson is currently a Director at Skogsmöllan AB, Kongsberg Beam Technology AS, and Investment Manager at Karolinska Development AB.
He was previously the Chief Executive Officer at SpectraCure AB, Annexin Pharmaceuticals AB, and Lund University Bioscience AB from 2007 to 2012.
He was also the Chairman at ProNoxis AB and Director at DermaGen AB.
Dr. Andersson holds a graduate and doctorate degree from the University of Lund.
Aktive Positionen von Thomas Andersson
Unternehmen | Position | Beginn |
---|---|---|
KAROLINSKA DEVELOPMENT AB | Corporate Officer/Principal | - |
Kongsberg Beam Technology AS
Kongsberg Beam Technology AS Miscellaneous Commercial ServicesCommercial Services Kongsberg Beam Technology AS develops and provides solutions for precise therapeutic radiation. The company was founded on August 2, 2005 and is headquartered in Kongsberg, Norway. | Direktor/Vorstandsmitglied | - |
Skogsmöllan AB
Skogsmöllan AB Pharmaceuticals: MajorHealth Technology Skogsmöllan AB is a private company based in Veberod, Sweden. The Swedish company provides pharmaceutical preparation services. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Thomas Andersson
Unternehmen | Position | Ende |
---|---|---|
ISOFOL MEDICAL AB | Vorstandsvorsitzender | 21.06.2023 |
Lund University Bioscience AB
Lund University Bioscience AB Investment ManagersFinance Lund University Bioscience AB (LU Bio) is an investment firm located in Lund, Sweden. In May 2007, LU Bio was founded by the parent firm, Lund University Development AB. They specialize in early-stage investments within the life sciences segment. Lund University was founded by the Swedish government in 1666. The university has three main research areas: medicine and pharmaceuticals, globally sustainable societal development, and the life sciences. | Vorstandsvorsitzender | 31.12.2012 |
ANNEXIN PHARMACEUTICALS AB | Vorstandsvorsitzender | - |
SPECTRACURE AB | Vorstandsvorsitzender | - |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Vorsitzender | - |
Ausbildung von Thomas Andersson
University of Lund | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ISOFOL MEDICAL AB | Health Technology |
SPECTRACURE AB | Electronic Technology |
KAROLINSKA DEVELOPMENT AB | Finance |
ANNEXIN PHARMACEUTICALS AB | Health Technology |
Private Unternehmen | 5 |
---|---|
DermaGen AB
DermaGen AB Pharmaceuticals: MajorHealth Technology DermaGen AB develops drugs and medical devices. It focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. The company was founded on February 2, 2004 and is headquartered in Solna, Sweden. | Health Technology |
Lund University Bioscience AB
Lund University Bioscience AB Investment ManagersFinance Lund University Bioscience AB (LU Bio) is an investment firm located in Lund, Sweden. In May 2007, LU Bio was founded by the parent firm, Lund University Development AB. They specialize in early-stage investments within the life sciences segment. Lund University was founded by the Swedish government in 1666. The university has three main research areas: medicine and pharmaceuticals, globally sustainable societal development, and the life sciences. | Finance |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
Kongsberg Beam Technology AS
Kongsberg Beam Technology AS Miscellaneous Commercial ServicesCommercial Services Kongsberg Beam Technology AS develops and provides solutions for precise therapeutic radiation. The company was founded on August 2, 2005 and is headquartered in Kongsberg, Norway. | Commercial Services |
Skogsmöllan AB
Skogsmöllan AB Pharmaceuticals: MajorHealth Technology Skogsmöllan AB is a private company based in Veberod, Sweden. The Swedish company provides pharmaceutical preparation services. | Health Technology |